Pure Global

Perioperative Respiratory Adverse events_sugammadex - Trial NCT05354466

Access comprehensive clinical trial information for NCT05354466 through Pure Global AI's free database. This phase not specified trial is sponsored by Seoul National University Hospital and is currently Recruiting. The study focuses on Respiratory Complication. Target enrollment is 174 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05354466
Recruiting
drug
Trial Details
ClinicalTrials.gov โ€ข NCT05354466
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Perioperative Respiratory Adverse events_sugammadex
Effect of Sugammadex Versus Neostigmine on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: a Randomized Controlled Trial

Study Focus

Respiratory Complication

Sugammadex injection

Interventional

drug

Sponsor & Location

Seoul National University Hospital

Seoul, South Korea

Timeline & Enrollment

N/A

Jun 27, 2022

Dec 31, 2023

174 participants

Primary Outcome

Perioperative respiratory adverse events

Summary

Perioperative respiratory adverse events are common in children. We aimed to evaluate the
 effect of sugammadex on the incidence of perioperative respiratory adverse events in
 pediatric patients receiving tonsillectomy

ICD-10 Classifications

Respiratory disorder, unspecified
Other respiratory disorders
Respiratory failure, unspecified
Other postprocedural respiratory disorders
Other specified respiratory disorders

Data Source

ClinicalTrials.gov

NCT05354466

Non-Device Trial